Pneumotox Online
v2.2
  • RSS Feed
  • Contact
  • News
  • Diagnosing DIRD
  • Browse
  • Available on AppStore Available on AppStore

The Drug-Induced Respiratory Disease Website

Philippe Camus, M.D.

Dijon, France

  • Home
  • Browse by »
  • Drugs
  • Patterns

Omalizumab

2

X.h Eosinophilic granulomatosis with polyangiitis (Churg-Strauss)

2
Last update : 01/05/2012
 
Search
Advanced search
Identify causative drugs
Diagnosing DIRD
1
Drug and radiation history
2
Drug singularity - Correct identification of the drug
3
Consistent timing of exposure v. onset of symptoms
4
Clinical, imaging, BAL, pathological pattern consistent with the specific drug
5
Careful exlusion of another cause
6
Remission of symptoms with removal of drug
7
Recurrence with rechallenge (rarely advisable)
8
Causality assessment
More detailed checklist

Publications

Omalizumab-associated eosinophilic granulomatosis with polyangiitis: cause or coincidence?
BMJ case reports 2021 Jul 29;14; 2021 Jul 29
Churg-strauss syndrome: clinical symptoms, complementary investigations, prognosis and outcome, and treatment.
Seminars in respiratory and critical care medicine 2011 Jun;32;298-309 2011 Jun
[Churg-Strauss syndrome under omalizumab treatment: a rare visceral manifestation].
Journal de radiologie 2009 Nov;90;1737-9 2009 Nov
Churg-strauss syndrome in patients treated with omalizumab.
Chest 2009 Aug;136;507-518 2009 Aug
Development of Churg-Strauss syndrome with controlled asthma during omalizumab treatment.
The Journal of allergy and clinical immunology 2008 Jan;121;253-4 2008 Jan

Powered by

  • ^
  • Contact
  • Cookies
  • About